Rilonacept in Subjects With Cardiac Sarcoidosis

NCT06660732 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cardiac Sarcoidosis

Interventions

DRUG: Rilonacept

Sponsor

Mayo Clinic

Collaborators

[object Object]